116 related articles for article (PubMed ID: 27881354)
1. [Analysis of immune suppression in patients with systemic lupus erythematosus complicated by herpes zoster virus infection].
Ouyang H; He XC; Zhou Y; Li ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1577-1581. PubMed ID: 27881354
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.
Deng Y; Ou YY; Mo CJ; Huang L; Qin X
Clin Rheumatol; 2023 Dec; 42(12):3299-3309. PubMed ID: 37537315
[TBL] [Abstract][Full Text] [Related]
3. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.
Borba EF; Ribeiro AC; Martin P; Costa LP; Guedes LK; Bonfá E
J Clin Rheumatol; 2010 Apr; 16(3):119-22. PubMed ID: 20216330
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster vaccination in SLE: a pilot study of immunogenicity.
Guthridge JM; Cogman A; Merrill JT; Macwana S; Bean KM; Powe T; Roberts V; James JA; Chakravarty EF
J Rheumatol; 2013 Nov; 40(11):1875-80. PubMed ID: 24037550
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
Mok CC; Ho LY; Tse SM; Chan KL; To CH
Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
[TBL] [Abstract][Full Text] [Related]
7. Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections.
Lu Z; Li J; Ji J; Gu Z; Da Z
Braz J Med Biol Res; 2019; 52(4):e8131. PubMed ID: 30994732
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
[TBL] [Abstract][Full Text] [Related]
9. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
10. [Herpes zoster in connective tissue diseases: I. Association with systemic lupus erythematosus and its immunological abnormalities].
Yamauchi Y; Nagasawa K; Tada Y; Tsukamoto H; Yoshizawa S; Mayumi T; Niho Y; Kusaba T
Kansenshogaku Zasshi; 1991 Jul; 65(7):851-6. PubMed ID: 1655920
[TBL] [Abstract][Full Text] [Related]
11. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
[TBL] [Abstract][Full Text] [Related]
12. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster in systemic lupus erythematosus.
Manzi S; Kuller LH; Kutzer J; Pazin GJ; Sinacore J; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Jul; 22(7):1254-8. PubMed ID: 7562754
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
Zamora LD; Collante MTM; Navarra SV
Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
[TBL] [Abstract][Full Text] [Related]
16. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders.
Pope JE; Krizova A; Ouimet JM; Goodwin JL; Lankin M
J Rheumatol; 2004 Feb; 31(2):274-9. PubMed ID: 14760796
[TBL] [Abstract][Full Text] [Related]
17. Decreased absolute numbers of CD3
Wei L; Zhao J; Wu W; Zhang Y; Fu X; Chen L; Wang X
Sci Rep; 2017 Nov; 7(1):15039. PubMed ID: 29118328
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
Chakravarty EF; Michaud K; Katz R; Wolfe F
Lupus; 2013 Mar; 22(3):238-44. PubMed ID: 23257402
[TBL] [Abstract][Full Text] [Related]
19. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
[TBL] [Abstract][Full Text] [Related]
20. Decreased blood levels of B lymphocytes and NK cells in patients with systemic lupus erythematosus (SLE) infected with papillomavirus (HPV).
Abud-Mendoza C; Cuevas-Orta E; Santillán-Guerrero EN; Martínez-Martínez MU; Hernández-Castro B; Estrada-Capetillo L; González-Amaro R; Baranda L
Arch Dermatol Res; 2013 Mar; 305(2):117-23. PubMed ID: 22752509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
